We are an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
+0.64 ( 1.918% )
Pricing delayed by 20 minutes
Last updated 08/03/2021 04:00 PM
What product are you looking for?